Immunogenicity Laboratory Services
Schedule a CallComprehensive immune response analysis for vaccine and therapeutic research
Our Immunology services provide advanced platforms and expertise to analyse immune responses critical for vaccine development, infectious disease research, and cardiometabolic programs. Leveraging cutting-edge technologies, we deliver reproducible, regulatory-compliant data.
- ELISA for protein and antibody quantification
- ELISpot for antigen-specific T cell analysis
- Multiplex cytokine and chemokine profiling
- Neutralization assays for binding and functional antibodies
- PBMC isolation and immune cell characterisation
- Immune Repertoire Sequencing
Applications for hVIVO Immunogenicity Laboratory Services
Vaccine development and immunogenicity studies
Infectious disease research
Cardiometabolic biomarker analysis
Benefits
- High-throughput, automated immunology workflows
- Regulatory-compliant processes
- Expert interpretation and reporting
We provide a broad range of immunology services designed to support drug discovery and clinical development. These include immune cell profiling, cytokine and biomarker analysis, functional immunoassays, and immune response characterisation, using established and fit‑for‑purpose methodologies.
Our immunology services support a variety of sample types, including whole blood, serum, plasma, PBMCs, and tissue‑derived samples. We work across early discovery, translational research, and clinical trial phases, ensuring assays are appropriately designed for each stage of development.
All immunology work is conducted using controlled laboratory processes with validated or qualified assays where required. We apply appropriate quality controls, scientific oversight, and documented workflows to ensure reliable, reproducible data that can confidently support development and regulatory decision‑making.
Related Resources
Explore our blogs and resources on Virus & Bacteria Production & Characterisation for Human Challenge Trials, covering GMP manufacturing and scientific characterisation approaches used to develop safe, infectious challenge agents for high-fidelity clinical studies.
Blog
Laboratory
Human challenge trials
Controlled Human Infection Model's (CHIM) in your backpack: how Human Challenge Trials support regulatory approval of travel vaccines
Andrew Catchpole
Chief Scientific Officer
10 Apr 2026
·
5 min read
Blog
Laboratory
Human challenge trials
Empowering Next‑Gen Infectious Disease & Vaccine Development
Elisa Masat
10 Apr 2026
·
3 min read
Blog
Laboratory
Human challenge trials
Enhancing Our Full-Service Offering: hVIVO’s New Bacteriology Lab
Chris Forsdyke
Head of Laboratory Services
10 Apr 2026
·
6 min read
Blog
Laboratory
Assay development
Advantages to Centralised Laboratory Services
Chris Forsdyke
Head of Laboratory Services
10 Apr 2026
·
4 min read
Blog
Laboratory
Assay development
Assays as Architecture: Building Blocks for Translational Research
Elisa Masat
10 Apr 2026
·
4 min read
Blog
Laboratory
Why NGS Is the Missing Link in Early‑Phase Infectious Disease Research
Martin Larke
24 Mar 2026
·
6 min read
Bring your challenge model to life with expert scientific support